CD40 signaling in vascular cells:: A key role in atherosclerosis?

被引:153
作者
Mach, F [1 ]
Schönbeck, U [1 ]
Libby, P [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Cardiovasc Div,Vasc Med & Atherosclerosis Unit, Boston, MA 02115 USA
关键词
T-lymphocytes; CD40; signaling; atherosclerosis;
D O I
10.1016/S0021-9150(97)00309-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is one of the most prevalent fatal diseases in Western societies, and results from an intricate interplay between diverse factors such as lipid metabolism, blood coagulation elements, cytokines, hemodynamic stress, and behavioral risk factors. Atherosclerotic lesions are characterized by the infiltration of immune competent cells such as macrophages and T-lymphocytes, the proliferation of intimal cells of the arterial wall, the accumulation of lipids and the deposition of extracellular matrix components. For some years, endothelial cells, smooth muscle cells, and macrophages have been accorded crucial roles in the process of atherosclerosis. The mechanisms by which these cells contribute to atherosclerosis include augmented expression of adhesion molecules, as well as secretion of proinflammatory cytokines, matrix metalloproteinases, and tissue factor within human and experimental atheroma. Much evidence supports the role of tissue factor in inciting the thrombosis that causes most acute coronary syndromes. Macrophage content and expression of tissue factor correlate with rupture and instability of the atherosclerotic plaque. Matrix metalloproteinases can digest the plaque's extracellular matrix, and thus impair its stability. Plaque rupture exposes circulating blood components to the tissue factor-rich lipid-core, inciting thrombosis. Despite the increasing appreciation that atherogenesis involves participation of inflammatory pathways within cellular interactions, mediators of local communication between the major cell types within atherosclerotic plaques remain incompletely defined. By early appearance, activated T-cells may act as the orchestrator of atherogenesis. Both soluble and contact-dependent mediators from T-cells may be crucial in the development of this prevalent disease. Recent reports have helped explain some of these questions by pointing to a role of contact dependent interaction between CD40 and CD40 ligand (CD40L, renamed CD154) as a stimulus for atheroma-associated cells. We and others have recently showed that activated T-lymphocytes within the atherosclerotic vessel wall express the CD40 ligand surface molecule, known to play a major role in several immunological pathways. In addition to activated T-lymphocytes, functional CD40 and CD40L are coexpressed by human vascular endothelial cells, smooth muscle cells and human macrophages in vitro as well as in situ in human atherosclerotic lesions. Recent studies indicate that CD40L activates atheroma-associated cells by promoting the expression of molecules thought to be involved in atherosclerosis, such as adhesion molecules, cytokines, matrix metalloproteinases, and tissue factor. Thus, CD40 ligation on these vascular wall cells may promote mononuclear cell recruitment, participate in the weakening of the plaque and set the stage for thrombosis, mechanisms of crucial importance in the process of atherosclerosis. The involvement of the CD40 signaling pathway may play major roles during atherogenesis by regulating antigen-specific T-cell responses to yield activation instead of tolerance, and the presence of functional CD40L on non-leukocytic cells associated with atherosclerotic lesion indicates a novel T-cell-independent route of inflammatory activation, a now well recognized component of atherogenesis. These findings establish a possible crucial role for CD40-CD40L interactions in a prevalent human disease. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:S89 / S95
页数:7
相关论文
共 53 条
  • [1] ADAM E, 1987, LANCET, V2, P291
  • [2] CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40
    ALDERSON, MR
    ARMITAGE, RJ
    TOUGH, TW
    STROCKBINE, L
    FANSLOW, WC
    SPRIGGS, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 669 - 674
  • [3] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    [J]. CELL, 1993, 72 (02) : 291 - 300
  • [4] ACTIVATION OF HUMAN B-CELLS MEDIATED THROUGH 2 DISTINCT CELL-SURFACE DIFFERENTIATION ANTIGENS, BP35 AND BP50
    CLARK, EA
    LEDBETTER, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4494 - 4498
  • [5] PREVENTION OF COLLAGEN-INDUCED ARTHRITIS WITH AN ANTIBODY TO GP39, THE LIGAND FOR CD40
    DURIE, FH
    FAVA, RA
    FOY, TM
    ARUFFO, A
    LEDBETTER, JA
    NOELLE, RJ
    [J]. SCIENCE, 1993, 261 (5126) : 1328 - 1330
  • [6] EMESON EE, 1988, AM J PATHOL, V130, P369
  • [7] STUDIES OF HYPERCHOLESTEROLEMIA IN THE NONHUMAN PRIMATE .2. FATTY STREAK CONVERSION TO FIBROUS PLAQUE
    FAGGIOTTO, A
    ROSS, R
    [J]. ARTERIOSCLEROSIS, 1984, 4 (04): : 341 - 356
  • [8] Immune regulation by CD40 and its ligand GP39
    Foy, TM
    Aruffo, A
    Bajorath, J
    Buhlmann, JE
    Noelle, RJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 591 - 617
  • [9] INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES
    GALIS, ZS
    SUKHOVA, GK
    LARK, MW
    LIBBY, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) : 2493 - 2503
  • [10] CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
    Gerritse, K
    Laman, JD
    Noelle, RJ
    Aruffo, A
    Ledbetter, JA
    Boersma, WJA
    Claassen, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2499 - 2504